Corticosteroids are the major contributors to the risk for serious infections in autoimmune disorders with severe renal involvement
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Corticosteroids are the major contributors to the risk for serious infections in autoimmune disorders with severe renal involvement
Authors
Keywords
-
Journal
CLINICAL RHEUMATOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-19
DOI
10.1007/s10067-021-05646-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The glomerular crescent
- (2020) Lidia Anguiano et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Initial high-dose corticosteroids and renal impairment are risk factors for early severe infections in elderly patients with antineutrophil cytoplasmic autoantibody-associated vasculitis
- (2020) Daisuke Waki et al. MEDICINE
- Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
- (2020) Michael Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Advances in therapeutic treatment options for ANCA-associated vasculitis
- (2020) Shealynn Carpenter et al. Expert Opinion on Orphan Drugs
- ANCA-associated vasculitis
- (2020) A. Richard Kitching et al. Nature Reviews Disease Primers
- Prevention of complications from use of conventional immunosuppressants: a critical review
- (2019) Claudio Ponticelli et al. JOURNAL OF NEPHROLOGY
- 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
- (2019) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- Associated clinical factors for serious infections in patients with systemic lupus erythematosus
- (2019) Ju-Yang Jung et al. Scientific Reports
- Has The Time Arrived to Refine The Indications of Immunosuppressive Therapy and Prognosis in IgA Nephropathy?
- (2019) Obrișcă et al. Journal of Clinical Medicine
- Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial
- (2019) Alexis Mathian et al. ANNALS OF THE RHEUMATIC DISEASES
- Changing patterns in clinical–histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis
- (2018) Gabriella Moroni et al. ANNALS OF THE RHEUMATIC DISEASES
- Histological predictors of renal outcome in lupus nephritis: the importance of tubulointerstitial lesions and scoring of glomerular lesions
- (2018) B Obrișcă et al. LUPUS
- Complications of Immunosuppression in Glomerular Disease
- (2018) J. Ashley Jefferson Clinical Journal of the American Society of Nephrology
- A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis
- (2018) Brad H. Rovin et al. KIDNEY INTERNATIONAL
- Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
- (2017) David R.W. Jayne et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Current and Emerging Therapies for Lupus Nephritis
- (2016) S. V. Parikh et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Investigations of Glucocorticoid Action in GN
- (2016) Christoph Kuppe et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971-2015: A Systematic Review and Bayesian Meta-Analysis
- (2016) Maria G. Tektonidou et al. Arthritis & Rheumatology
- Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials
- (2014) J. Robson et al. RHEUMATOLOGY
- Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
- (2013) Marie B Condon et al. ANNALS OF THE RHEUMATIC DISEASES
- C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN
- (2013) H. Xiao et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Life-Threatening Cryoglobulinemic Patients With Hepatitis C
- (2013) Soledad Retamozo et al. MEDICINE
- Lymphopenia and Treatment-Related Infectious Complications in ANCA-Associated Vasculitis
- (2012) R. Goupil et al. Clinical Journal of the American Society of Nephrology
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
- (2010) Rachel B. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis
- (2009) M. A. Little et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for the management of primary small and medium vessel vasculitis
- (2008) C Mukhtyar et al. ANNALS OF THE RHEUMATIC DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now